GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind,…
Read MoreBreaking News
-
Flower One Holdings Inc. ("Flower One" or the "Company") (CSE: FONE) (OTCQB: FLOOF) is pleased…
-
Many countries have legalized cannabis on some level, however, regulations regarding actually growing the plant…
-
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high…
-
CMTREX 2018 Ltd (CMTREX) and Theracann International Benchmark Corporation (Theracann) today announced that they have…
-
February is American Heart Month and Candy Head, the makers of CBD edibles, wants U.S. consumers…
-
1933 Industries Inc. (the "Company" or "1933 Industries") (CSE: TGIF) (OTCQX: TGIFF) (FWB: 1QF) a…
-
Liht Cannabis Corp. ((CSE: LIHT) (OTCQX: LIHTF) or the "Company") announces today that it has…
-
Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, announced today that it has entered into…
-
Precision Extraction Solutions ("Precision"), a market leader in cannabis and hemp extraction technology, has been…
-
Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM), announced…
